News

Biotech Reports Positive Preclinical COVID-19 Study Results

June 17, 2021 (Investorideas.com Newswire) These data and next steps for Novan’s antiviral SB019 are provided in a ROTH Capital Partners report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News

News

Bonds Didn’t Disappoint

December 3, 2021 (Investorideas.com Newswire) S&P 500 sharply rebounded, and signs are it has legs. ...
Next Article:

0 %